Directorio de personas
Anabel Sorolla Bardaji

Anabel Sorolla Bardaji

Grado: Doctor/a


asorolla(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/E-2546-2012

Publicaciones

  • Marqués M; Pont M; Hidalgo I; Sorolla MA; Parisi E; Salud A; Sorolla A; Porcel JM

    MicroRNAs Present in Malignant Pleural Fluid Increase the Migration of Normal Mesothelial Cells In Vitro and May Help Discriminate between Benign and Malignant Effusions.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 24 -. .

    [doi:10.3390/ijms241814022]

  • Pont, M; Marques, M; Sorolla, MA; Parisi, E; Urdanibia, I; Morales, S; Salud, A; Sorolla, A

    Applications of CRISPR Technology to Breast Cancer and Triple Negative Breast Cancer Research

    Cancers 15 -. .

    [doi:10.3390/cancers15174364]

  • Parisi, E; Hidalgo, I; Montal, R; Pallise, O; Tarragona, J; Sorolla, A; Novell, A; Campbell, K; Sorolla, MA; Casali, A; Salud, A

    PLA2G12A as a Novel Biomarker for Colorectal Cancer with Prognostic Relevance

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 24 -. .

    [doi:10.3390/ijms241310889]

  • Parisi E; Marqués M; Pont M; Sorolla MA; Sorolla A

    Editorial: Transcription Factors Drivers of Malignancy, Progression and Poor Outcomes in Breast Cancer.

    Frontiers in oncology 12 912542-912542. .

    [doi:10.3389/fonc.2022.912542]

  • Porcel, JM; Sorolla, A; Parisi, E; Bielsa, S; Salud, A; Sorolla, MA

    Cell-free DNA Concentration and Pattern Fragmentation in Pleural Fluid and Plasma to Detect Malignant Effusions.

    Annals of the American Thoracic Society 19 854-856. .

    [doi:10.1513/AnnalsATS.202107-810RL]

  • Marques, M; Sorolla, MA; Urdanibia, I; Parisi, E; Hidalgo, I; Morales, S; Salud, A; Sorolla, A

    Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers?

    Cancers 14 -. .

    [doi:10.3390/cancers14051101]

  • Sorolla, A; Parisi, E; Sorolla, MA; Marques, M; Porcel, JM

    Applications of CRISPR technology to lung cancer research.

    EUROPEAN RESPIRATORY JOURNAL 59 -. .

    [doi:10.1183/13993003.02610-2021]

  • Sorolla, MA; Hidalgo, I; Sorolla, A; Montal, R; Pallise, O; Salud, A; Parisi, E

    Microenvironmental Reactive Oxygen Species in Colorectal Cancer: Involved Processes and Therapeutic Opportunities

    Cancers 13 -. .

    [doi:10.3390/cancers13205037]

  • Gandhi NS; Wang E; Sorolla A; Kan YJ; Malik A; Batra J; Young KA; Tie WJ; Blancafort P; Mancera RL

    Design and Characterization of a Cell-Penetrating Peptide Derived from the SOX2 Transcription Factor.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 22 -. .

    [doi:10.3390/ijms22179354]

  • Sorolla MA; Marqués M; Parisi E; Sorolla A

    An N-ethyl-N-Nitrosourea Mutagenesis Screen in Mice Reveals a Mutation in Nuclear Respiratory Factor 1 (Nrf1) Altering the DNA Methylation State and Correct Embryonic Development.

    Animals 11 -. .

    [doi:10.3390/ani11072103]

  • Sorolla MA; Sorolla A; Parisi E; Salud A; Porcel JM

    Diving into the Pleural Fluid: Liquid Biopsy for Metastatic Malignant Pleural Effusions.

    Cancers 13 -. .

    [doi:10.3390/cancers13112798]

  • Golden E; Rashwan R; Woodward EA; Sgro A; Wang E; Sorolla A; Waryah C; Tie WJ; Cuyàs E; Ratajska M; Kardas I; Kozlowski P; Johnstone EKM; See HB; Duffy C; Parry J; Lagerborg KA; Czapiewski P; Menendez JA; Gorczynski A; Wasag B; Pfleger KDG; Curtis C; Lee BK; Kim J; Cursons J; Pavlos NJ; Biernat W; Jain M; Woo AJ; Redfern A; Blancafort P

    The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer.

    Nature Communications 12 1920-1920. .

    [doi:10.1038/s41467-021-22101-7]

Proyectos

  • DEVELOPMENT OF PRECISION THERAPIES FOR TRIPLE NEGATIVE BREAST CANCERS BASED ON CRISPR/CAS9 RIBONUCLEOPROTEINS.
  • Development of precision therapies for triple negative breast cancer based on CRISPR/Cas12a ribonucleoproteins
  • Contrato Miguel Servet - Proyecto + RRHH
  • EXPRESION DE CANALES DE CALCIO DE TIPO T EN NEOPLASIAS MELANOCÍTICAS BENIGNAS Y MALIGNAS. EVALUACION DE SU APLICICABILIDAD CLINICA COMO DIANAS TERAPEUTICAS EN EL MELANOMA